<!DOCTYPE html>
<html lang="en">
  <head>
    <meta charset="UTF-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <title>Anderson EMS Pocket Medic</title>
    <link rel="icon" href="../favicon.ico" type="image/png" />
    <link rel="stylesheet" href="../OB.css" />
    <link rel="stylesheet" href="Eclampsia.css" />
  </head>
  <body>
    <a href="../../../index.html" class="header-link">
      <div class="header">
        <h1>Anderson EMS Pocket Medic</h1>
      </div>
    </a>

    <div class="MainBody">
      <h2>Eclampsia / Pre-Eclampsia</h2>

      <div class="InitialBody">
        <table class="StartTable">
          <thead>
            <tr>
              <th>History</th>
              <th>Signs and Symptoms</th>
              <th>Differential</th>
            </tr>
          </thead>
          <tbody>
            <tr>
                <td>
                    • Past medical history<br><br>
                    • Hypertension medications<br><br>
                    • Prenatal care<br><br>
                    • Prior pregnancies / births<br><br>
                    • Gravida / Para
                </td>
                <td>
                    • Hypertension
                    • Seizures<br><br>
                    • Severe headaches<br><br>
                    • Visual changes<br><br>
                    • Edema of hands and face<br><br>
                    • Abdominal pain
                </td>
                <td>
                    • Pre-eclampsia<br><br>
                    • Eclampsia<br><br>
                    • Seizures<br><br>
                    • Hypertension

                </td>
            </tr>
          </tbody>
        </table>
        <p>
            <span class="purpleCenter">Definitions</span><br>
            <span class="center"><i>Female patients > 20 weeks gestation and &lt; 4 weeks post-partum</i></span><br><br>
            <strong><u>Pre-Eclampsia:</u></strong> In the setting of pregnancy, hypertension defined as a SBP > 140 or DBP > 90 mmHg in previously
            normotensive patient. Symptoms of headache, vision changes, confusion, abdominal pain, pulmonary edema.<br><br>

            <strong><u>Eclampsia:</u></strong>: Pre-Eclampsia with the development of seizures. 
        </p>
        <h3 class="AllLevels">EMR & EMT</h3>
        <p>
            1. <a href="../../General/UniversalSources/Universal.html" title="Universal Patient Care SOG" class="working-link">UNIVERSAL PATIENT CARE</a>.<br><br>
            2. Obtain history and vital signs.<br><br>
            <span class="Indention">
                a. Gestational age or recent post-partum.<br><br>
                b. Symptoms suggestive of end organ involvement such as headache, confusion, visual disturbances,
                seizure, epigastric pain, right upper quadrant pain, nausea and vomiting.<br><br>
                c. Previous history of hypertension or known pre-eclampsia.
            </span><br>
            3. Place patient in left lateral recumbent position.<br><br>
            4. Relay information to incoming ambulance or call for intercept per  
            <a href="../../General/InterceptCriteriaSources/Intercept.html" class="working-link" title="Intercept Criteria SOG">INTERCEPT CRITERIA</a>.

        </p>
        <h3 class="PARAMEDIC">Paramedic/PHRN</h3>
        <p>
            1. Continue <strong>EMR/EMT TREATMENT</strong>.<br><br>
            2. Establish IV access.<br><br>
            3. If pregnant patient is experiencing pertinent signs and symptoms with severe hypertension defined as a SBP >
            160 or DBP > 110 mmHg in previously normotensive patient, administer:<br><br>
            • <a href="../../../DrugMaterial/LabetalolFolder/labetalol.html" title="Labetalol Med Page" class="working-link">LABETALOL</a>
            <strong>20 mg IV over 2 minutes</strong>. May repeat every 10 min X2 with a goal to reduce MAP by 20-
            25%. <i>Do not administer initial dose or repeat dose if heart rate is less than 60 bpm.</i><br><br>
            <span class="Indention">
                <strong>(OR)</strong>
            </span><br>
            • <a href="../../../DrugMaterial/HydralazineFolder/hydralazine.html" class="working-link" title="Hydralazine Med Page">HYDRALAZINE</a> <strong>5 mg IV</strong>. 
            May repeat <strong>10mg</strong> after 20 min for persistent hypertension if MAP has not
            been reduced by 20-25% after the initial dose.<br><br>

            4. If pregnant patient develops seizures, administer <a href="../../../DrugMaterial/MagnesiumFolder/magnesium.html" class="working-link" title="Magnesium Med Page">MAGNESIUM SULFATE</a>
            <strong>10g</strong> (5g/10mL x 2 (one dose per
            buttock)) <strong>IM or 4g IV infusion over 2 minutes</strong> <i>(See below):</i><br><br>
            <span class="Indention">
                • For IV/IO administration, Pre-mixed <a href="../../../DrugMaterial/MagnesiumFolder/magnesium.html" class="working-link" title="Magnesium Med Page">MAGNESIUM SULFATE</a>
                 <strong>4g</strong> , 50 mL or100mL<br><br>
                 <span class="Indention">
                    <strong>(OR)</strong>
                </span><br>
                • For IV/IO administration, draw 8 mL of 50% <a href="../../../DrugMaterial/MagnesiumFolder/magnesium.html" class="working-link" title="Magnesium Med Page">MAGNESIUM SULFATE</a>
                <strong>(4g/8mL)</strong> in a 30 mL syringe and
                then draw 22 mL of Normal Saline
            </span><br>
            5. Seizures not responsive to magnesium, contact medical control and refer to <a href="../../AdultMedical/SeizureSources/Seizure.html" class="working-link" title="Seizure Protocol">SEIZURE / STATUS
            EPILEPTICUS</a><br><br>
            <span class="medcontrol" style="font-size: 2em">☎️ Medical Control ☎️</span>
            <br>
            6. If pregnant patient is experiencing pertinent signs and symptoms pre-eclampsia with severe hypertension
            defined as a SBP > 160 or DBP > 110 mmHg in previously normotensive patient, contact medical control for
            guidance regarding the administering of <a href="../../../DrugMaterial/MagnesiumFolder/magnesium.html" class="working-link" title="Magnesium Med Page">MAGNESIUM SULFATE</a>.
        </p>
        <p>
            <strong>PEARLS</strong><br><br>

            • Delivery of the placenta is the only definitive management for pre-eclampsia and eclampsia.<br><br>
            • Early treatment of severe pre-eclampsia with magnesium and anti-hypertensive significantly reduces the rate
            of eclampsia - use of magnesium encouraged if signs of severe pre-eclampsia present to prevent seizure.<br><br>
            • Seizure activity secondary to eclampsia may present greater than 20-weeks post-partum. History of preeclampsia during pregnancy with no prior history of seizure activity, is a strong indicator of a post-partum
            presentation of an eclamptic seizure.<br><br>
            • Magnesium toxicity (progression)<br><br>
            <span class="Indention">
                a. Hypotension followed by<br><br>
                b. Loss of deep tendon reflexes followed by<br><br>
                c. Somnolence, slurred speech followed by<br><br>
                d. Respiratory paralysis followed by<br><br>
                e. Cardiac arrest
            </span><br>
            • Treatment of magnesium toxicity
        </p>

        <table class="EndTable">
          <thead>
            <tr>
              <th><strong>KEY DOCUMENTATION ELEMENTS </strong></th>
              <th><strong>PERTINENT ASSESSMENT FINDINGS </strong></th>
            </tr>
          </thead>
          <tbody>
            <tr>
                <td>
                    • Document full vital signs and physical findings<br><br>
                    • Document neurologic exam
                </td>
                <td>
                    • Vital signs assessment with repeat blood pressure
                    monitoring before and after treatment<br><br>
                    • Assessment of deep tendon reflexes after
                    magnesium therapy<br><br>
                    • Examination for end organ involvement
                </td>
            </tr>
          </tbody>
        </table>
        <table class="QMTable">
          <tr>
            <td><strong>QUALITY METRICS</strong><br /><br /></td>
          </tr>
          <tr>
            <td>
                • Patients with signs of hypertension and great than 20-weeks gestation or recent post-partum should be assess
                for signs of pre-eclampsia<br /><br />
                • Recognition and appropriate treatment of eclampsia
            </td>
          </tr>
        </table>
      </div>
    </div>
    <script src="https://code.jquery.com/jquery-3.7.1.min.js"></script>
    <script src="Eclampsia.js"></script>
  </body>
  <footer class="footer">
    <p>&copy; 2025 LukiWebSolutions. All rights reserved.</p>
  </footer>
</html>
 